文献速递痛风与晶体性关节病

痛风发作强度评分(GAIS)的研发与验证:患者报告结局工具

Development and validation of a patient-reported gout attack intensity score for use in gout clinical studies.
PubMed 文献 · Rheumatology (Oxford) · 2019-01-01

本研究基于一项比较阿那白滞素与标准治疗急性痛风发作的随机对照试验数据,开发并验证了包含疼痛、肿胀和压痛三个条目的患者报告痛风发作强度评分(GAIS)。Mokken量表分析支持各条目可扩展性,GAIS信度良好(最大下界>0.80),对变化有高效应量(>0.8)的反应性,且区分应答者与非应答者优于单个条目,无地板 ceiling 效应。

要点

  • GAIS由疼痛、肿胀、压痛三个5点评分条目组成,信度良好(最大下界>0.80)。
  • GAIS对变化反应性高(效应量>0.8),区分应答者优于单个条目。
  • GAIS无地板和天花板效应,适用于痛风临床研究。

核心结论

  • GAIS似乎是评估患者报告痛风发作强度的可靠且反应性良好的工具,可用于痛风临床研究。

研究设计与样本

  • 基于一项比较阿那白滞素与标准治疗急性痛风发作的随机对照试验数据,患者完成7天发作日记,包含疼痛、肿胀和压痛强度的5点评分条目。

主要发现

  • Mokken量表分析支持单个条目的可扩展性,GAIS评分可靠(最大下界>0.80)。
  • GAIS评分显示对变化的反应性,效应量高(>0.8),且区分应答者与非应答者优于其单个条目成分。
  • 未发现地板和天花板效应。

关键数值与推荐

  • GAIS信度:最大下界>0.80;反应性:效应量>0.8;条目为5点评分。

临床怎么用

  • 在痛风临床研究中,可使用GAIS作为患者报告痛风发作强度的总结测量指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Inflammation-related symptoms such as pain, swelling and tenderness of the affected joint are frequently assessed using 5-point diary rating scales in gout clinical trials. Combining these into a single gout attack symptom intensity score may be a useful summary measure for these data, which is potentially more responsive to change compared with the individual components. The objective of this study was to develop a patient-reported gout flare intensity score, the Gout Attack Intensity Score (GAIS), for use in clinical studies, that includes components for gout-related pain, swelling and tenderness. METHODS: Data from a randomized controlled trial comparing anakinra to standard of care for the treatment of acute gout attacks were used for this study. A 7-day flare diary was completed by patients, including questions relating to intensity of pain, swelling and tenderness (5-point rating scales). Scalability of these items was assessed using Mokken Scale Analysis, and reliability using greatest lower bound reliability coefficients. Known-groups validity was evaluated, as well as the responsiveness to change and the presence of floor and ceiling effects. RESULTS: Scalability of the single items was supported, and GAIS scores were reliable (greatest lower bound >0.80). GAIS scores demonstrated responsiveness to change with high effect sizes (>0.8), and discriminated better between responders and non-responders compared with its single-item components. No floor and ceiling effects were found. CONCLUSION: The GAIS seems to be a reliable and responsive instrument for assessing patient-reported gout attack intensity that may be used in gout clinical studies.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Janssen CA, Oude Voshaar MAH, Ten Klooster PM, et al. Development and validation of a patient-reported gout attack intensity score for use in gout clinical studies. Rheumatology (Oxford). 2019. PMID: 30859221. doi:10.1093/rheumatology/kez064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。